ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

November 21, 1980

NCI selects nanotech centers for funding.

October 14, 2005

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992